Effect of oestrogen receptor status and time on the intra-tumoural accumulation of tamoxifen and N-desmethyltamoxifen following short-term therapy in human primary breast cancer

Breast Cancer Research and Treatment

Volumn 28, Issue 3, 1993, Pages 241-250

  Johnston, S R D ^a   Haynes, B P ^b   Sacks, N P M ^a   McKinna, J A ^a   Griggs, L J ^b   Jarman, M ^b   Baum, M ^a   Smith, I E ^a   Dowsett, M ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

breast cancer; intra tumoural tamoxifen; oestrogen receptor status; short term therapy

Indexed keywords

ESTROGEN RECEPTOR; TAMOXIFEN; TAMOXIFEN DERIVATIVE;

ADULT; AGED; ARTICLE; BREAST CANCER; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; DRUG ACCUMULATION; DRUG RESPONSE; DRUG TISSUE LEVEL; FEMALE; HUMAN; PRIORITY JOURNAL;

AGED; BREAST NEOPLASMS; COMPARATIVE STUDY; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE; FEMALE; HUMAN; MIDDLE AGE; NEOPLASMS, HORMONE-DEPENDENT; RECEPTORS, ESTROGEN; SUBCELLULAR FRACTIONS; SUPPORT, NON-U.S. GOV'T; TAMOXIFEN;

EID: 0027716732     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/BF00666585     Document Type: Article

References (24)

1. Hormone receptors: their role in predicting prognosis and response to endocrine therapy
2. Metabolites of tamoxifen in animals and man: identification, pharmacology and significance
3. Determination of tamoxifen and biologically active metabolites in human breast tumours and plasma
4. Determination of tamoxifen and four metabolites in serum by low-dispersion liquid chromatography
5. Comparative binding affinities of tamoxifen, 4-hydroxytamoxifen, and desmethyltamoxifen for estrogen receptors isolated from human breast carcinoma; correlation with blood levels in patients with metastatic breast cancer
6. Tamoxifen metabolites in patients on long-term adjuvant therapy for breast cancer
7. Serum concentrations of tamoxifen and major metabolites during long-term Nolvadex therapy, correlated with clinical response
8. Distribution of tamoxifen and its metabolites in rat and human tissues during steadystate treatment
9. Distribution of tamoxifen and metabolites into brain tissue and brain metastases in breast cancer patients
10. Acquired tamoxifen resistance: correlation with reduced breast tumour levels of tamoxifen and isomerisation of trans-4-hydroxytamoxifen
11. Derivatives of tamoxifen - Dependence of antioestrogenicity on the 4-substituent
12. Receptors reconsidered: a 20 year perspective
13. Determination of tamoxifen and an unhydroxylated metabolite in plasma from patients with advanced breast cancer using gas chromatography mass spectrometry
14. Identification and biological activity of tamoxifen metabolites in human serum
15. Clinical pharmacology of tamoxifen in patients with breast cancer: comparison of traditional and loading dose schedules
16. Determination and pharmacology of a new hydroxylated metabolite of tamoxifen observed in patient sera during therapy for advanced breast cancer
17. Paired-ion chromatographic analysis of tamoxifen and two major metabolites in plasma
18. The measurement of tamoxifen and metabolites in the rat and relationship to the response of DMBA-induced mammary tumours
19. High affinity anti-oestrogen binding site distinct from the oestrogen receptor
20. Characterisation and quantitation of anti-oestrogen binding sites in oestrogen receptor positive and negative human breast cancer cell lines
21. High affinity specific antioestrogen binding sites are concentrated in rough microsomal membranes of rat liver
22. Comparative affinity of steroidal and non-steroidal antioestrogens, cholesterol derivatives and compounds with a dialkylamino side chain for the rat liver antioestrogen binding site
23. How cancer cells evade chemotherapy: Sixteenth Richard and Hinda Rosenthal Foundation Award Lecture
24. Tamoxifen and the isomers of 4-hydroxytamoxifen in tamoxifen-resistant tumours from breast cancer patients